Kyung Nam Pharm Co., Ltd. logo

Kyung Nam Pharm Co., Ltd. (053950)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
1,671. 00
-6
-0.3578%
32.9B Market Cap
- P/E Ratio
160% Div Yield
31,597 Volume
- Eps
1,677
Previous Close
Add Transaction
Day Range
1,652 1,700
Year Range
1,415 5,580
Want to track 053950 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

053950 closed today lower at ₩1,671, a decrease of -0.3578% from yesterday's close, completing a monthly decrease of -3.5776% or -₩62. Over the past 12 months, 053950 stock gained 145.3744%.
053950 pays dividends to its shareholders, with the most recent payment made on Jan 05, 2005.
Kyung Nam Pharm Co., Ltd. has completed 2 stock splits, with the recent split occurring on Apr 14, 2026.
The company's stock is traded on one exchange.

053950 Chart

People also search for

Fine M-Tec Co., Ltd.
8,930
-2.5109%
Genexine Co., Ltd.
2,755
+1.2868%
TiumBio Co., Ltd.
4,950
-1.5905%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,160
0%

Kyung Nam Pharm Co., Ltd. (053950) FAQ

What is the stock price today?

The current price is ₩1,671.00.

On which exchange is it traded?

Kyung Nam Pharm Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 053950.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 160%.

What is its market cap?

As of today, the market cap is 32.9B.

Has Kyung Nam Pharm Co., Ltd. ever had a stock split?

Kyung Nam Pharm Co., Ltd. had 2 splits and the recent split was on Apr 14, 2026.

Kyung Nam Pharm Co., Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
7 May 2026 Last Split
- IPO Date

Overview

Kyung Nam Pharm Co., Ltd. is a renowned entity within the pharmaceutical landscape, renowned for its comprehensive production and distribution of an extensive range of healthcare solutions. This company is acclaimed for its dynamic role in developing therapeutic answers aiming to meet diverse medical requirements from pain management to the betterment of cardiovascular and gastrointestinal health. Markedly involved in rigorous research and development efforts, Kyung Nam Pharm is committed to the creation of innovative drugs and health supplements, setting a benchmark in quality and safety that aligns with international standards. Catering to both local and international markets, the company underscores its influence in the pharmaceutical realm, significantly contributing to the enhancement of public health and the progression of medical science. Consequently, it stands as a pivotal supporter of healthcare systems worldwide, driving forward the agenda for improved global wellness.

Products and Services

  • Pain Management Solutions

    Kyung Nam Pharm Co., Ltd. offers a suite of products specifically designed to alleviate various types of pain, facilitating improved quality of life for individuals suffering from chronic or acute conditions. These solutions underscore the company’s dedication to addressing one of the most universal healthcare needs.

  • Cardiovascular Health Therapies

    Understanding the critical nature of cardiovascular wellness, the company has developed a line of pharmaceuticals aimed at managing and preventing heart-related ailments. These therapies support the maintenance of heart health, addressing conditions such as hypertension and cholesterol imbalances.

  • Gastrointestinal Wellbeing Products

    To combat a spectrum of gastrointestinal issues, Kyung Nam Pharm provides a range of products designed to promote digestive health. This includes treatments for common conditions like acid reflux, ulcers, and irritable bowel syndrome, emphasizing the company’s role in enhancing gastrointestinal wellness.

  • Research and Development Initiatives

    At the core of Kyung Nam Pharm Co., Ltd.'s mission is its continuous investment in research and development. These initiatives are pivotal in the discovery and innovation of new pharmaceuticals and health supplements, ensuring the company remains at the forefront of medical science advancements and capable of responding to evolving health challenges.

Contact Information

Address: -
Phone: -